Doctors warned not to give melatonin to children with sleep disorders
Health & Medical
A LEADING sleep researcher has warned that the increasingly common practice of prescribing melatonin for children with sleep disorders is risky because there has been no safety studies of the drug.
Sign up to receive notifications about new stories in this category.
Thank you for subscribing to story notifications.
Professor David Kennaway, Head of the Circadian Physiology Laboratory at the University of Adelaide's Robinson Research Institute, warns that providing melatonin supplements to children may result in serious side effects when the children are older.
Melatonin is a hormone produced in the body with the onset of darkness. It plays an important role in fine-tuning people's circadian rhythms, such as the timing of sleep onset, as well as other biological processes.
“The use of melatonin as a drug for the treatment of sleep disorders for children is increasing and this is rather alarming,” Professor Kennaway says.
“Melatonin is registered in Australia as a treatment for primary insomnia only for people aged 55 years and over, but it's easily prescribed as an 'off label' treatment for sleep disorders for children.”
Professor Kennaway says there is extensive evidence from laboratory studies that melatonin causes changes in multiple physiological systems, including cardiovascular, immune and metabolic systems, as well as reproduction in animals.
“Melatonin is also a registered veterinary drug which is used for changing the seasonal patterns of sheep and goats, so they are more productive for industry. If doctors told parents that information before prescribing the drug to their children, I'm sure most would think twice about giving it to their child,” Professor Kennaway says.
“The word 'safe' is used very freely and loosely with this drug, but there have been no rigorous, long-term safety studies of the use of melatonin to treat sleep disorders in children and adolescents.
“There is also the potential for melatonin to interact with other drugs commonly prescribed for children, but it's difficult to know without clinical trials assessing its safety.”
Professor Kennaway, who has been researching melatonin for the past 40 years, says these concerns have largely been ignored throughout the world.
“Considering the small advances melatonin provides to the timing of sleep, and considering what we know about how melatonin works in the body, it is not worth the risk to child and adolescent safety,” he says.
Professor Kennaway research was published in the Journal of Paediatrics and Child Health.
Jump to next article
